PVG.L Regulatory News (PVG)

23 Jun 2005 08:41

Ark Therapeutics Group PLC23 June 2005 23 June 2005 Ark Therapeutics Group plc Director's Share Dealing Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that itwas informed on 22 June 2005 that Dr Nigel Parker, CEO, exercised options over500,000 ordinary Ark shares of 1 pence each on 22 June 2005. These shares,which represent approximately 0.39% of the Company's issued share capital, weresubsequently sold at a price of 109 pence per share. Following thistransaction, Dr Parker will own 2,886,667 ordinary Ark shares, representing 2.3%of the Company's issued share capital. The shares sold represent 7% of Dr Parker's total holding of options and shares.Dr Parker has informed the Company that he does not anticipate selling anyfurther shares in the foreseeable future. - Ends - This information is provided by RNS The company news service from the London Stock Exchange